中文速读
本研究使用Engreen的Entranster-R4000转染试剂将AT149(5'PPP dsRNA)转染至HEK293细胞,验证其通过RIG-I受体激活先天免疫,并作为佐剂与SARS-CoV-2 Delta-Omicron嵌合RBD二聚体重组蛋白疫苗联合免疫小鼠,显著提高免疫原性和交叉中和抗体水平。
小鼠HEK-Lucia Null cells with RIG-I overexpressionHEK-Lucia Null cells with RIG-I knockoutHEK-Lucia Null cells RIG-I Null
A Novel Targeted RIG-I Receptor 5’Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein Vaccine
Affiliations
- 1 Division of Hepatitis and Enterovirus Vaccines, Institute of Biological Products, National Institutes for Food and Drug Control, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing 102600, China.
- 2 Shanghai JunTuo Biotechnology Co., Ltd., Shanghai 201210, China.
- 3 Beijing Minhai Biotechnology Co., Ltd., Beijning 102600, China.
- PMID: 37243185
- PMCID: PMC10220529
- DOI: 10.3390/v15051099
Free PMC article
Abstract
The rapid mutation and spread of SARS-CoV-2 variants recently, especially through the emerging variants Omicron BA5, BF7, XBB and BQ1, necessitate the development of universal vaccines to provide broad spectrum protection against variants. For the SARS-CoV-2 universal recombinant protein vaccines, an effective approach is necessary to design broad-spectrum antigens and combine them with novel adjuvants that can induce high immunogenicity. In this study, we designed a novel targeted retinoic acid-inducible gene-I (RIG-I) receptor 5’triphosphate double strain RNA (5’PPP dsRNA)-based vaccine adjuvant (named AT149) and combined it with the SARS-CoV-2 Delta and Omicron chimeric RBD-dimer recombinant protein (D-O RBD) to immunize mice. The results showed that AT149 activated the P65 NF-κB signaling pathway, which subsequently activated the interferon signal pathway by targeting the RIG-I receptor. The D-O RBD + AT149 and D-O RBD + aluminum hydroxide adjuvant (Al) + AT149 groups showed elevated levels of neutralizing antibodies against the authentic Delta variant, and Omicron subvariants, BA1, BA5, and BF7, pseudovirus BQ1.1, and XBB compared with D-O RBD + Al and D-O RBD + Al + CpG7909/Poly (I:C) groups at 14 d after the second immunization, respectively. In addition, D-O RBD + AT149 and D-O RBD + Al + AT149 groups presented higher levels of the T-cell-secreted IFN-γ immune response. Overall, we designed a novel targeted RIG-I receptor 5’PPP dsRNA-based vaccine adjuvant to significantly improve the immunogenicity and broad spectrum of the SARS-CoV-2 recombinant protein vaccine.
Keywords: immunogenicity; recombinant protein vaccine; retinoic acid-inducible gene-I (RIG-I) receptor; vaccine adjuvant.
小核酸转染试剂Entranster™-R4000 已有 223 篇已发表文献
同类研究
- Biomolecules. 2026 May 19;16(5):741.doi: 10.3390/biom16050741. Up-Regulation of the TRPM8 Channel Attenuates TRPC1-Media…
- FASEB J. 2026 May 15;40(9):e71855.doi: 10.1096/fj.202503895RR. High-Fat Diet Induces Inflammatory Injury in Mice Sertoli…
- Biochem Pharmacol. 2026 Jan 20:246:117723.doi: 10.1016/j.bcp.2026.117723. Small nucleolar RNA host gene 3 regulates seps…
- Autoimmunity. 2025 Dec;58(1):2576881.doi: 10.1080/08916934.2025.2576881. High glucose promotes O-GlcNAcylation of ACSL4…
- BMC Cancer. 2025 Oct 10;25(1):1553.doi: 10.1186/s12885-025-14854-x. PCBP1-AS1 facilitates liver metastasis in pancreatic…